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[ 1146-1591 Myocardial Blood Flow and Flow Rourve In 
Chi ld ren  A f te r  Arter ia l  Sw i tch  P rocedure  
C S, Ouvemoy', M. Hauser, C, Meyer, I Mntsunan, K BtJhlmeyer, 
M, Schwa~ler 'DnnsmnotCat(1~r~/og~, UnwePMyotMch~#an, AnnArOo~, MI, 
USA: Departments of Nuclear Mecltcme an# F~ed~atno Card~othorac~c 
Surgery4, Technm_.al UnNetsdy of Munch. Munch, Germany 
~l~(gro~ut~;/: Children born with trsnsposd~on of the groat vessels currently 
undergo en arfenal switch pfoo~Jum in the neonatal I~no¢l, rind are flubse. 
quefltly largely asymptom~tm. Them is a low incidence_ O1 perfuslon dete~ts In 
this P~l~daben. 
Me&~d~ We assessed myocardml b~oad flow [MBF) end my~.ard,al vas. 
Ctl~ar esmtarme (MVR) at rest and duneg maximal hyperemm using N.13 
ammonia PET before and after intravenous adenosine mh~s~on i  8 children 
( 11 ± 2 ym) etatus post artenal sw~ch m the neonatal penod, all ot whom had 
no evide~'e of ~schem,a 0y exercise ECG and stress echocardmgrap~y. MBF 
and CFR values were Compared w~lh 9 healthy young adult volunteers (34 
10 yrs). 
Patasnt~ 074 t: 013 10~ ~: 24 24B ~: 04a 31¢a 339~08 
No=ma~s 0~9 t O0? 133 ~ 20 2z3 = 029 31~7 400 ~ 062 
p v~,tue NS 0 04 NS NS 0 04 
Resu/ts: PET was we, tolerated ~ art ch*kJren. Rasing and hyperem~e 
MBF was nol s~gruhcantb/ ~fferent between subtects and normals, but CFR 
was s~jP~f v,.-antly lower m patterns. No c~l  had a CFR value more than 2.5 SD 
below the average t~r no,mats. A stress-reduced perfu~on detect was noted 
m I portent; ttus pabe,~ lad  Ihe ~west CFR vak~ as well. 
~ :  MyocarJ~al bk~od flow ~s ~thm normal range in children wrth 
surc3ca~ corrected transpo~t~n of the gmal artenes, although CFR m re- 
clucecl when compared with young adu~. PET  may be a useful quantstaWe 
tool to ~or  changes m come, an/flow m pa~ents w~th congenial heart d~s- 
ease. Its ~,in~cat s c3~f~c~nc-e r mains u~proven 
1146-1601 The Medium Tet'm in Arteries Rndings Coronary  
) 
by  In tn lvascu la r  U l t rasound in  In fants  and  
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MA. Kuh~. K.R. Jutzy, S.D. Frrtzsche, C.E. Cephus~ O.D. Der:-. ,-t~. 
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CAUSA 
Background. Intravascu~r ultrasound (IVUS) has been shown to be a ~m'zs,- 
tP.,e tool m the detection of post-transptam coronan/artery d~sease (PTCAD) 
cn adults. Smiter findings have been seen in mA~al studies wd'h chddren 
Methods: Th~s study compared the medium term findings ot IVUS ~n ct~l- 
dmn who tmderwem heat1 transplant (htx) at > 1 yr of age (gp 1 ) to those who 
undemmnt htx at - 1 yr of age (gp 2). Between 7/96 and 6,~J7, 30 chddren 
(ojp 1: n = 17, gp 2. n = 13) had IVUS gerformed at the time of the annual 
cathetenzat~n. A total of 390 segments were evaluated m 39 vessels (LAD 
25, Cx 4. RCA 10). Mean total area (TA). mean lumen area (LA), maxm~al 
mbmal thickness (MIT). and mbmal index (11) (TA-LA/TA) were cafcutated by 
ptammet~. The degree O! intzmal thK~kenmg was dassdied using the Stanford 
scale, The pabent demographics are shown ~n the tabte below. 
Age al ht~ Age al catn Years s~r'~l~ ht~ 
Gpl 10 ~ 5 y','s 14 ~ 5y'm 4 ± 2y~s 
Gp2 2 * 2mos 8 ± ly~s 8z lyre 
ResultS: Companson of MIT and II are shown in the table below. 
Gp 1 Gp 2 D-value 
MIT (mm) 026 ± 0 14 : 004 0 001 
II (%) 11 ± 7 7 ± 3 004 
Both MIT and II were significantly greater in gp 1 than in gp 2. PTCAD 
based on the Stanford classification (see table to the nght) was more severe 
in gp I compared to gp 2. The number of reiection episodes correlated with the 
MIT in gp 1 (r = 0.56. p = 0.02), but not in gp 2 (r = 0.21, p = 05). The number 
0! reiection episodes did not differ bah'men the h'ro groups. CMV status did 
not correlate in either group. 
Class I 2 3 4 
Gp 1 7 6 3 1 
Gp 2 10 3 0 0 
Conclusions: This study suggests that medium term survivors who had a 
htx at <1 yr of age had less PTCAD detected by WUS when competed to 
medium term survivors who had a htx > 1 yr of age. 
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~ A l lopur lno l  Imprevea  Endothe l l l l  Funct ion  In 
NIDDM, but  Me no  E f f~" t  tl l A~KI-mat¢~ 
Young Non.¢i iabetk:  Cont ro l s  
R Bgller t , A,D, Morfl~ ~, A,D: Slrutt~= t , 'Ut~'et~rty Df~oarfrnent ofCling.at 
Pha~t~,  Nfnev~ P,o~p~al nd I~d~caI Sc~o~, Ou,',d~e, PO~ ~ 
UK~ Un~ve~ffy~rtmentot l~mke, Nrnew~t l~ta lan~l  
Schoot, Dundee, DD! 9SY, UK 
Backgroun~ Them is evidence thai anti.oxidant therapies improve endothe. 
hal function (EF) in diabetic, palient.  ^ ~ lh lne  ox~Jase i~ a key flee red,cat 
enzyme generst~ system and Iherefore allopunnol, a =anthme oxidase m- 
h,brtor may produce a s~milar benef~a! effects on EF 
Methc~: We examined 34 patients (11 patmnts with NIDDM, mean age 
(MA) = 65 years; 12 similar aged corffmls, MA = 59 years and 11 your~ 
healthy volunteers, MA = 25 years) treated w~lh 300 mg of allopunno! (1 
month) in a ranclommed, plaeeOo Corltfolled, double-blind, crees--over study 
EF was assossecl by bilateral forearm venous occlusmn plethyemography 
using endothelhal dependent (acetyl ct~olme) and endothehat independent va- 
soddatalors (sodium nt~opruss~e). 
Resu/~" Forearm Mood flow (FBF) response to acstyl choline showo~ a 
s,geffieant increase w~ allopurmol therapy in the NIDDM subgroup (2.63 vs 
2.16 m~100 mlstmm; allopormol v,s placebo p = 0.01; 95% C! 0.11,0.83) but no 
,mpro~w~ent w~th nrtrop~usside. There was a s~gnfftcant redtJ~O~ in mak:~yl- 
~ad le l '~  (MDA) (0.30 vs 0.34 pMA; altopunnel vs placebo p = 002). There 
was no ~,terence m t-lbA1C, choleslerol or I~ood pressure between the study 
days. There was no stgmficaof d~fference between erlher endathehal depen- 
dS ,  or independent response in e~ther the young or old normal subgroups. 
Th~_e r ~  indicate for the flint t~me [nat the altopunnol improves EF but 
only ,n NIDDM. Allopuenol may decrease tree ra~:al generstion increasing 
nltnc oxide h(oavailab~lrty. 
~ A  Comparative Study of Four Anti-hypertensive 
Agents  on  Endothe l ia l  Funct ion  in Pat ients With 
Coronary  Diaease 
T.J. Anderson 1 . R.W. Overhiser, H. Haber, F Charbenneau ~ 'Foo~dts 
HosprtaL Calgary, Canada; : Royal Victoria Hosprtal, Montreal, Canada 
Back~.,'ouncl- Qumapnl, an ACE rn~or  w~n hlgh affinrty, has been shown to 
tmpreve coronary endothef,al dyshJnctmn in patlents with CAD. The effectwve- 
ness of different vasoact~ve agents to fmprove human endothehal function ~s 
unknown. In t l~ BANFF stucty, we used I~gh resolution ultrasound to ~ r e  
tr~e chromc effects of four arm-hypertenswes on brachial artery flow-mediated 
vasodllatTon (FMD) m patmnts wTth documented CAD 
Method's: Patients were enrolled in a pa~al-bleck, cross-over des=gn tnal, 
and randomized m one of four different, open label drug sequences. The core 
ultrasound lab and data analys~s center were masked to treatment. F"MD and 
NTG-mducod ddatton were evaluated before and after 8 weeks of each study 
drug, Two week washout was imposed between treatments. 
ResuRs: CAD patients had s~jmfpcanfty m'~paired FMD (6.2 ± 0.6%, n = 80) 
compared to normals (10.9 ± 08%, N = 40, p ~ 0.05). Absolute changes m 
FMD from baseline am shown below. 
Drug N 3FMD (Mean t SE) p vahm 
Oulnapn120 mg 56 1 8 "-. 1 0% - 0 02 
Enalapnl Omg 55 02  "- 08% 084 
Losartart 50 mg 38 08 *.- 1 1% 0 57 
Amt(~l=plrte 5 mg 45 0 3 ~ 0 9". 0 97 
No szgn!hcanr d~ffefe~ces ,n NTG.~nduced d.'~t,on w~m observed 
Conclusron: Only qumapnl was associated with significant ~mprovement 
,n flow mediated dilation. ACE mh=bRors may differ =n the,r ablhty to rmprove 
vascular endothelial function. 
~ Adenosine and Nitrates Interaction at Coronary 
Macro- and  Mic roc i rcu la tory  Level in Pat ients  
With Syndrome X 
C. Palombo. M Koz~,kov~. G. Biga[li, M eel Tecta CNR Clinical Phystol~ 
Inshtute and Chair of Pharmacology.. Unrversrly of P~sa, /tat}, 
Background: an endothelial dysfunction is reported in Syndrome X (SX). In 
